Selected key takeaway from our 2026 Annual Conference: BTOG 2026 Nurse of the Year Award presented by Tom Newsom-Davis. Full recordings and presentations available to members on our website. #LCSM #lungcancer

Missed our #SCLC webinar, or want to revisit the discussion?

Watch the replay of Fast diagnosis, fragmented support: living with small-cell #lungcancer in Europe.

We’ve also added answers to audience Qs, including those we couldn’t cover live.

lungcancereurope.eu/news/fast-di...

#LCSM

Key takeaway from our 2026 Conference: Malnutrition incidence in lung cancer patients at NCCC outpatient clinic. Full details for members. #LCSM #lungcancer

Faculty convened at an OncLive Workshop to discuss HER2-mutant NSCLC testing, treatment selection, and sequencing strategies. @ddoroshow.bsky.social @ucdavis.bsky.social @ucirvine.bsky.social @cityofhope.bsky.social @danafarber.bsky.social #lcsm #oncology

www.onclive.com/view/tkd-mut...

2️⃣ conferences at once! Get ready for #SOHO2026 in Houston and #WCLC26 in Seoul!
🤠 Over the next few days, we’ll be covering the two conferences in-depth with expert insight all on our site! 🇰🇷
@societyofhemonc.bsky.social @iaslc.bsky.social #lcsm #leusm #mmsm #mpnsm #lymsm #oncology #hematology

Thank you @europeanrespsoc.bsky.social for an excellent #ERSCongress2026 in Barcelona.

We presented 2 abstracts, contributed to discussions on #lungcancer & made new connections across respiratory health.

Read our round-up:
lungcancereurope.eu/news/lung-ca...

Now on to #WCLC26 in Seoul ✈️ #LCSM

🚨BREAKING: The @fda.gov has granted accelerated approval to sevabertinib (Hyrnuo) for the treatment of patients with locally advanced/metastatic nonsquamous NSCLC harboring HER2 (ERBB2) TKD activating mutations, as detected by an FDA-authorized test #lcsm #oncology

www.onclive.com/view/fda-app...

Scotland has confirmed routine NHS access to lorlatinib after previous ALK+ lung cancer treatment.

It had been available on an interim basis since 2020. Following reassessment and further evidence, that access is now routine.

#ALKPositive #LungCancer #LCSM

THIS JUST IN 📣: Anticipated data from the phase 3 DeLLphi-305 trial of durvalumab plus tarlatamab in first-line extensive-stage small cell lung cancer have been released! #lcsm #oncology #medtwitter

Here's everything you need to know 🔎: www.onclive.com/view/durvalu...

Want to know what to look for at #WCLC26? Sign up for exclusive insights from @drcamidge.bsky.social, of @cumedicalschool.bsky.social, and @lungoncdoc.bsky.social, of @mdanderson.bsky.social! @iaslc.bsky.social #lcsm #oncology

See the full preview on our site: www.onclive.com/view/camidge...

Key takeaway from our 2026 Annual Conference: Lung cancer in never smokers at Guy's Cancer Centre by Alexandra Holdich. Full recordings available to members. #LCSM #lungcancer

It’s #WorldRadiotherapyAwarenessDay.

Radiotherapy can also play an important role in ALK+ #lungcancer. It may be used to treat cancer in the brain or other parts of the body, control one or a small number of areas that have started growing, or relieve symptoms.

#LCSM

New microplastics research presented at #ERSCongress today studied 100 people undergoing tests for lung symptoms.

Microplastics were found in lung-wash samples from 66% of those diagnosed with #LungCancer, compared with 46% of those without it.

lungcancereurope.eu/news/news/mi... #LCSM

Innovate UK invests £25.4M to advance early cancer diagnosis. Apply by 28 Oct 2026! Details: https://ow.ly/8rYh50ZCn28 #CancerHealthcareGoals #LCSM #LungCancer

At #ERSCongress2026 today?

Come and meet us from 12:00–13:00 at the @europeanlung.bsky.social stand in the World Village and talk to us about #LungCancer in Europe. #LCSM

People affected by #lungcancer do not share their experiences with us so they can sit in a report.

At #ERSCongress, we’re taking what they told us into wider discussions and presenting two abstracts on Tuesday: one on SCLC and one on storytelling in lung cancer awareness. #LCSM

📢 #BTOG2027 abstract submissions open! Submit by 7 Dec 2026. Register for 25th BTOG, 3–5 Mar 2026, EICC Edinburgh. Join UK's top thoracic oncology! 🔗 https://btog.org/25th-btog-annual-conference-2027 #LCSM

200+ people have registered for today’s #SCLC webinar. There’s still time to join us.

We’ll hear from people living with SCLC and others affected by it, alongside clinicians, about diagnosis, treatment and support.

15:00 CEST / 14:00 BST

lungcancereurope.eu/sclc-webinar...

#LungCancer #LCSM

New research is helping us understand why ALK targeted treatments can stop working.

In 148 people with ALK+ #lungcancer, researchers identified changes in the RAS pathway as one possible route of resistance.

An important clue for future research.

#ALKPositive #LungCancer #LCSM